DWRX5003 safety and relative bioavailability to DWC202502 and DWC202503 evaluated in healthy adults
A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers
Abstract
DWRX5003's safety and relative bioavailability compared to DWC202502 and DWC202503 were assessed in a Phase 1 trial in healthy adults.